| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_692dc75829481c48c017b52f352e2bad |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-802
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-416 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L67-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L29-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L29-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-91 |
| filingDate |
2008-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2d2a65a0d587797dc261e44b1f4ed55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_054eeb4ca2c0c113484b158bc596c49c |
| publicationDate |
2010-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2191853-A1 |
| titleOfInvention |
In-vivo indwelling matter |
| abstract |
It is intended to provide an in-vivo indwelling device, for example, an in-vivo indwelling device which has a high safety and a low risk of causing breakage of a coating layer formed on a surface of a stent during production or transportation of the stent, and moreover, when the stent is expanded during clinical use, or an in-vivo indwelling device with which a decrease in side effects of a remaining medicinal agent resulting from eliminating the medicinal agent as quickly as possible can be expected and which can carry a medicinal agent in a minimum amount necessary for suppressing restenosis. Such an object of the invention can be achieved by an in-vivo indwelling device which has an in-vivo indwelling device main body and a layer containing a medium-chain fatty acid triglyceride formed on at least a part of a surface of the in-vivo indwelling device main body and is put indwelling in a lumen in-vivo. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107998458-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107998458-A |
| priorityDate |
2007-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |